CH EPL (R5)
1.0.0-ci-build - ci-build Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

: PhP Budesonidum-Suspension - XML Representation

Raw xml | Download


<AdministrableProductDefinition xmlns="http://hl7.org/fhir">
  <id value="PhP-Budesonidum-Suspension"/>
  <meta>
    <profile
             value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition PhP-Budesonidum-Suspension</b></p><a name="PhP-Budesonidum-Suspension"> </a><a name="hcPhP-Budesonidum-Suspension"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-administrableproductdefinition.html">CH IDMP AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Entocort-Solvent-and-Tablet.html">MedicinalProductDefinition: extension = Tablet and solvent for rectal suspension,Distale Form der Colitis ulcerosa bei ungenügendem Ansprechen auf oder Kontraindikation für Mesalazin.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7601001346451-5204201; combinedPharmaceuticalDoseForm = Tablet and solvent for rectal suspension; indication = Leichte bis mittelschwere Colitis ulcerosa des Rectums sowie des Colon sigmoideum.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = budesonide,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{http://standardterms.edqm.eu 11006000}">Rectal suspension</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{http://standardterms.edqm.eu 15009000}">Bottle</span></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://standardterms.edqm.eu 20061000}">Rectal use</span></td></tr></table></div>
  </text>
  <status value="active"/>
  <formOf>🔗 
    <reference
               value="MedicinalProductDefinition/Entocort-Solvent-and-Tablet"/>
  </formOf>
  <administrableDoseForm>
    <coding>
      <system value="http://standardterms.edqm.eu"/>
      <code value="11006000"/>
      <display value="Rectal suspension"/>
    </coding>
  </administrableDoseForm>
  <unitOfPresentation>
    <coding>
      <system value="http://standardterms.edqm.eu"/>
      <code value="15009000"/>
      <display value="Bottle"/>
    </coding>
  </unitOfPresentation>
  <routeOfAdministration>
    <code>
      <coding>
        <system value="http://standardterms.edqm.eu"/>
        <code value="20061000"/>
        <display value="Rectal use"/>
      </coding>
    </code>
  </routeOfAdministration>
</AdministrableProductDefinition>